Bioinformatics analysis of calcium-dependent protein kinase 4 (CDPK4) as Toxoplasma gondii vaccine target

Masoud Foroutan1, Ali Dalir Ghaffari2, Shahrzad Soltani1

  • 1USERN Office, Abadan Faculty of Medical Sciences, Abadan, Iran.

BMC Research Notes
|February 7, 2021
PubMed
Abstract

Insights

This study analyzes the Toxoplasma gondii CDPK4 protein using bioinformatics, predicting its structure, immunogenicity, and potential as a vaccine target against T. gondii infection.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Bioinformatics

Background:

  • Toxoplasma gondii (T. gondii) is an intracellular parasite affecting warm-blooded animals, including humans.
  • Calcium-dependent protein kinases (CDPKs) are crucial for T. gondii functions like host cell invasion and division.

Purpose of the Study:

  • To analyze the physicochemical properties and structural characteristics of the T. gondii CDPK4 protein.
  • To predict potential B-cell and T-cell epitopes for vaccine development.
  • To evaluate the antigenicity and allergenicity of the CDPK4 protein.

Main Methods:

  • Utilized various bioinformatics online servers for protein analysis.
  • Predicted molecular weight, aliphatic index, and GRAVY score.
  • Employed SOPMA and GOR4 tools for secondary structure prediction.
  • Analyzed Ramachandran plot for tertiary structure validation.
  • Predicted B-cell and T-cell epitopes using multiple bioinformatics tools.
  • Assessed antigenicity and allergenicity of the CDPK4 protein.

Main Results:

  • The CDPK4 protein consists of 1158 amino acid residues with a molecular weight of 126.331 KDa.
  • Secondary structure analysis indicated significant percentages of alpha-helix, random coils, and extended strands.
  • Ramachandran plot analysis showed a high proportion of residues in favored and allowed regions.
  • Several potential B-cell and T-cell epitopes were identified.
  • The CDPK4 protein was predicted to be immunogenic and non-allergenic.

Conclusions:

  • Bioinformatic analysis provides a foundational understanding of the T. gondii CDPK4 protein.
  • The identified epitopes and immunogenic nature suggest CDPK4 as a potential target for vaccine development.
  • Further research based on these findings could lead to effective vaccines against T. gondii infections.